SPRING HALL GROUP PRACTICE
173C SPRING HALL LANE, HALIFAX
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 107 | 112 | 95.5% | |
| CKD 4 | 2008 | 173 | 188 | 92.0% | |
| CKD 5 | 2009 | 30 | 36 | 83.3% | |
| CKD 5 | 2010 | 54 | 58 | 93.1% | |
| CKD 5 | 2011 | 72 | 87 | 82.8% | |
| CKD 5 | 2012 | 83 | 92 | 90.2% | |
| CKD 5 | 2013 | 82 | 92 | 89.1% | |
| CKD003 | 2014 | 116 | 136 | 85.3% | |
| CKD003 | 2015 | 104 | 115 | 90.4% | |
| NM84 | 2016 | 99 | 114 | 86.8% | |
| NM84 | 2017 | 89 | 105 | 84.8% | |
| NM84 | 2018 | 71 | 91 | 78.0% | |
| NM84 | 2019 | 60 | 85 | 70.6% | |
| NM84 | 2020 | 80 | 110 | 72.7% | |
| NM84 | 2022 | 63 | 84 | 75.0% | |
| NM84 | 2023 | 63 | 83 | 75.9% |
